Who can argue with a computer printout?
So why would an elderly person with a total cholesterol level of 190 be terrified and put on medication that has been shown to cause cancer in rodents at normal dosages? (Read the fine print that comes with the prescription.)
Found on pae 196, NUTRITIONAL ASSESSMENT, Robert D. Lee,
David C. Nieman, 1993.
mg/dL Desirable <10 Borderline high 11-24 High >25
Effects of Lipid-Modifying Drugs on HDL, Dense LDL, Triglycerides,
Lipoprotein Property Nicotinic Acid Statins Fibrates Resins Comination of Nicotinic Acid and Statin HDL Levels Increase (Average 25-40%, Rante 0-100%) Increase (3-10%) Increase (TG 500 3-5%, TG more 1000 35%) No Change Increase (Average 35%) TG Levels Decrease (Average 30-70%, Range 0-95%) Decrease (TG Less 500 10-30%, TG more 1000 40-50%) Decrease (TG less 500 25%, TG more 100 65-80%) No change to increase Decrease (Average 75%) LDL Particle Density Decrease in dense (pattern B) LDL by up to 90%, Increase in buoyant (pattern A) LDL by up to 20% Dramatic Decrease in dense (pattern B) LDL, Decrease in buoyant (pattern A) LDL Increase in desnse (Pattern B) LDL by 15-150%, Increase in buoyant (pattern A) LDL by 25-140% Decrease in dense (pattern B) LDL, Increase in buoyant (pattern A) LDL Decrease in dense (pattern B) LDL, Average 80-90%, Decrease in buoyant (pattern A) LDL Lp(a) Levels Decrease (Average 15-35%, Range 0-50%) No Change No Change No Change Decrease (Average 15-35%)
Table supplied by Atherotech
The Cholesterol Myth
Back to Hidden Cures for Heart Disease